Liver resection yields limited success in HCC patients with hepatitis B/C coinfectionJuly 26, 2021Hepatocellular Carcinoma
Laparoscopic repeat liver resection shows safety for recurrent HCC patientsJuly 26, 2021Hepatocellular Carcinoma
Anatomical liver resection surpasses nonanatomical resection for overall survival in HCCJuly 26, 2021Hepatocellular Carcinoma
Lenvatinib extends time to disease progression in HCC patients with portal vein tumor thrombusJuly 26, 2021Hepatocellular Carcinoma
Statin use shows dose-dependent reduction in the risk of hepatocellular carcinoma in hepatitis B patientsJuly 26, 2021Hepatocellular Carcinoma
TARE beats systemic therapy for survival benefits in hepatocellular carcinoma with major vascular invasionJuly 26, 2021Hepatocellular Carcinoma
TARE extends health-related quality of life in HCC patients versus sorafenibJuly 26, 2021Hepatocellular Carcinoma
Novel biomarker shows promise as predictor of post-hepatectomy outcomes in HCCJuly 23, 2021Hepatocellular Carcinoma
Microwave ablation and robot-assisted hepatectomy yield similar outcomes for HCCJuly 23, 2021Hepatocellular Carcinoma
Combination atezolizumab and bevacizumab succeeds in real-world settingJuly 23, 2021Hepatocellular Carcinoma
Microsphere concentration matters in DEB-TACE for hepatocellular carcinomaJune 24, 2021Hepatocellular Carcinoma
Overall survival rates similar between intrahepatic cholangiocarcinoma and hepatocellular carcinomaJune 24, 2021Hepatocellular Carcinoma
Atezolimab plus bevacizumab prompts strong early response in unresectable HCCJune 24, 2021Hepatocellular Carcinoma
HCC patients report quality of life issues including frustration, fear, and fatigueJune 24, 2021Hepatocellular Carcinoma
Adding dexamethasone curbs post-embolization syndrome after TACE for HCCJune 24, 2021Hepatocellular Carcinoma
